These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1779259)

  • 1. Cefaclor in the treatment of infective exacerbations of chronic bronchitis in cigarette smokers.
    Cazzola M; Franco C; Gioia V; Legnani D; Mancini V; Polverino M; Sevieri G
    J Chemother; 1991 Aug; 3(4):245-9. PubMed ID: 1779259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections.
    Dark D
    Am J Med; 1991 Sep; 91(3A):31S-35S. PubMed ID: 1656740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis.
    Gotfried MH; Ellison WT
    Am J Med; 1992 Apr; 92(4A):108S-113S. PubMed ID: 1316059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbation of chronic bronchitis.
    Cazzola M; Di Perna F; Boveri B; Di Marco F; Diamare F; Centanni S
    J Chemother; 2000 Jun; 12(3):216-22. PubMed ID: 10877516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
    DeAbate CA; Henry D; Bensch G; Jubran A; Chodosh S; Harper L; Tipping D; Talbot GH
    Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefaclor AF: correlation of microbiology and clinical outcome.
    Thornsberry C
    Postgrad Med J; 1992; 68 Suppl 3():S10-6. PubMed ID: 1287612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of cefaclor and tetracycline in the treatment of bacterial bronchitis.
    Hurst DJ
    Clin Ther; 1984; 6(2):163-9. PubMed ID: 6231104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefaclor AF versus cefaclor in acute exacerbations of chronic bronchitis.
    Grossman RF
    Postgrad Med J; 1992; 68 Suppl 3():S30-6; discussion S36-7. PubMed ID: 1287616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Smoking and lower respiratory tract infection].
    Brown RB
    Infection; 1987; 15 Suppl 3():S123-8. PubMed ID: 3610332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial isolates and cigarette smoking in patients with chronic bronchitis: results from an Italian multicenter survey.
    Cazzola M; Ariano R; Gioia V; Mancini V; Rimoldi R; Scala G; Scoccia S; Girbino G
    Clin Ther; 1990; 12(2):105-17. PubMed ID: 2112984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefpodoxime proxetil suspension compared with cefaclor suspension for treatment of acute otitis media in paediatric patients.
    MacLoughlin GJ; Barreto DG; de la Torre C; Pinetta EA; del Castillo F; Palma L
    J Antimicrob Chemother; 1996 Mar; 37(3):565-73. PubMed ID: 9182113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of S 6472 granule preparation (sustained-release cefaclor) in chronic bronchitis].
    Hiraga Y; Omichi M; Sasaoka S
    Jpn J Antibiot; 1988 Sep; 41(9):1304-8. PubMed ID: 3241328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute bronchitis and pneumonia with cefaclor.
    Mattson K; Renkonen OV; Laitinen L; Nikander-Hurme R
    Postgrad Med J; 1979; 55 Suppl 4():59-61. PubMed ID: 398482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acute bacterial bronchitis and pneumonia with cefaclor.
    Mogabgab WJ; Pollock B; Beville RB; Gentry LO; Jemsek JG
    Postgrad Med J; 1979; 55 Suppl 4():62-6. PubMed ID: 44908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized double-blind controlled trial of roxithromycin and cefaclor in the treatment of acute lower respiratory tract infections in general practice.
    Tilyard MW; Dovey SM
    Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):97S-101S. PubMed ID: 1617932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
    Alanis A; Longest KA; Senetar JE; Dere WH
    Postgrad Med J; 1992; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefaclor af versus amoxycillin/clavulanate in acute bacterial exacerbations of chronic bronchitis: a randomised multicentre study.
    Bandak SI; Bolzon LD; Turnak MR; Johns D; Henle SK; Allen BS
    Int J Clin Pract; 1999 Dec; 53(8):578-83. PubMed ID: 10692750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefpodoxime proxetil in the treatment of lower respiratory tract infections.
    Geddes AM
    Drugs; 1991; 42 Suppl 3():34-40. PubMed ID: 1726206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers.
    Pasqua F; Biscione G; Crigna G; Cazzola M
    Ther Adv Respir Dis; 2008 Aug; 2(4):209-14. PubMed ID: 19124373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections.
    Hoepelman AI; Sips AP; van Helmond JL; van Barneveld PW; Neve AJ; Zwinkels M; Rozenberg-Arska M; Verhoef J
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():147-52. PubMed ID: 8396086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.